Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Agios Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- −1 vs. Q4 2024
- Shares held
- 60.1M
- +417.7K (+0.7%) vs. Q4 2024
- Total value
- $1.76B
- −$198.2M (−10.1%) vs. Q4 2024
- New holders
- 38
- 73 more added
- Sold out
- 39
- 78 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ArrowMark Colorado Holdings LLC | 827,623 | $24.2M | 0.39% | −89,797−9.8% | Reduced |
| Citadel Advisors LLC | 863,499 | $25.3M | 0.02% | −570,177−39.8% | Reduced |
| Deutsche Bank AG | 928,970 | $27.2M | 0.01% | −6,282−0.7% | Reduced |
| Fisher Asset Management, LLC | 959,339 | $28.1M | 0.01% | −1,322−0.1% | Reduced |
| Polar Capital Holdings Plc | 1,002,036 | $29.4M | 0.18% | +375,000+59.8% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,025,719 | $30.1M | 0.08% | +83,530+8.9% | Added |
| JPMorgan Chase & Co | 1,049,360 | $30.7M | 0.00% | +34,000+3.3% | Added |
| Frazier Life Sciences Management, L.P. | 1,069,854 | $31.3M | 1.43% | +1000.0% | Added |
| Bank of America Corp | 1,135,592 | $33.3M | 0.00% | +730,690+180.5% | Added |
| Dimensional Fund Advisors LP | 1,262,073 | $37.0M | 0.01% | −66,992−5.0% | Reduced |
| Geode Capital Management, LLC | 1,394,581 | $40.9M | 0.00% | +44,930+3.3% | Added |
| Macquarie Group Ltd | 1,850,544 | $54.2M | 0.07% | +165,551+9.8% | Added |
| Armistice Capital, LLC | 2,048,000 | $60.0M | 1.60% | −216,304−9.6% | Reduced |
| Commodore Capital LP | 2,185,000 | $64.0M | 4.72% | +2,185,000 | New |
| Erste Asset Management GmbH | 2,229,900 | $65.4M | 0.84% | +220,000+10.9% | Added |
| Price T Rowe Associates Inc | 2,301,353 | $67.4M | 0.01% | −122,184−5.0% | Reduced |
| State Street Corp | 2,449,479 | $71.8M | 0.00% | +297,202+13.8% | Added |
| Bellevue Group AG | 3,515,150 | $103.0M | 2.31% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,108,746 | $149.7M | 0.00% | +92,486+1.8% | Added |
| Vanguard Group Inc | 5,604,591 | $164.2M | 0.00% | −26,730−0.5% | Reduced |
| Farallon Capital Management, L.L.C. | 5,700,466 | $167.0M | 0.90% | +26,000+0.5% | Added |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −1,073,755−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −417,208−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −276,439−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −248,038−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −169,550−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −141,073−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −109,373−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −69,971−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −47,326−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −45,817−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −38,580−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −32,790−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −30,584−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −28,553−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −25,735−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −25,735−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −23,839−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −23,274−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,229−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,200−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −18,105−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −15,520−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −9,160−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −8,485−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −7,804−100.0% | Sold out |
| Contravisory Investment Management, Inc. | 0 | $0 | 0.00% | −6,752−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −6,501−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,863−100.0% | Sold out |
| Wingate Wealth Advisors, Inc. | 0 | $0 | 0.00% | −1,606−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −529−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −123−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Bayforest Capital Ltd | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Parkworth Wealth Management, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |
| Cassady Schiller Wealth Management, LLC | – | – | – | – | Not filed |